|
Class 2 Device Recall Phadia 2500EE instrument |
|
Date Initiated by Firm |
May 01, 2023 |
Date Posted |
June 30, 2023 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-2041-2023 |
Recall Event ID |
92365 |
510(K)Number |
K093459
|
Product Classification |
Antibodies, gliadin - Product Code MST
|
Product |
Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma (Li-heparin, EDTA) to aid in the diagnosis of celiac disease Material Number 12410002
|
Code Information |
UDI: 07333066020938
All Serial Numbers |
Recalling Firm/ Manufacturer |
Phadia US Inc 4169 Commercial Ave Portage MI 49002-9701
|
For Additional Information Contact |
SAME 269-833-1819
|
Manufacturer Reason for Recall |
Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Themofisher Scientific/Phadia US issued Urgent Medical Device Recall Letter-Medical Device Field Safety Notice issued May 1, 2023. Letter states reason for recall, health risk and action to take:
d13 EliA U/mL (due to risk of false positive EliA GliadinDP IgG results in this range) according to your internal procedures.
Log files may only be available for analysis for a limited timeframe on the Phadia Laboratory System due to storage and maintenance restrictions and may not cover the entire timeframe of the Instrument message log.
" As noted above in section 1.3, also review test results for Total IgA and EliA Celikey IgA (if tested) to identify potential IgA deficient patients.
" Should you need help, contact Phadia US Technical Support who can further assist in collecting log files and aid in identifying the potentially impacted test results.
2) Use of the EliA GliadinDP IgG Well on Phadia 2500EE can continue as detailed in the user manual and the DfU with the following recommendations:
" For EliA GliadinDP IgG results that fall in the range of e10 to d13 EliA U/mL (due to risk of false positive EliA GliadinDP IgG results) and are IgA deficient:
a. Verify positive EliA GliadinDP IgG results using a Phadia 250 instrument if available. Use the result generated on the Phadia 250 to report patient results in line with the user manual and DfU.
b. As another option, you may wish to verify positive EliA GliadinDP IgG results by running EliA Celikey IgG on your existing, Phadia 2500EE. It is important to note that EliA Celikey IgG is not a direct alternative for EliA GliadinDP IgG and results generated are not readily interchangeable. Both EliA tests are designed to assist in the diagnosis of celiac disease. Further scientific background on this recommendation can be provided by Phadia s US Technical Support team.
c. If you do not have direct access to a Phadia 250 instrument in your laboratory or utilize EliA Celikey IgG, please contact Phadia s US Technical Suppor |
Quantity in Commerce |
9 units |
Distribution |
US: CA, NJ, MI
|
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database |
510(K)s with Product Code = MST and Original Applicant = PHADIA US INC.
|
|
|
|